Warning! GuruFocus detected
3 Severe warning signs
with YB3.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Shin Nippon Biomedical Laboratories Ltd
ISIN : JP3379950003
Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.76 | |||||
| Debt-to-EBITDA | 4.61 | |||||
| Interest Coverage | 18.52 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.54 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.5 | |||||
| 3-Year EBITDA Growth Rate | 17.4 | |||||
| 3-Year EPS without NRI Growth Rate | 20.3 | |||||
| 3-Year Book Growth Rate | 29.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.96 | |||||
| 9-Day RSI | 35.26 | |||||
| 14-Day RSI | 38.58 | |||||
| 3-1 Month Momentum % | -3.52 | |||||
| 6-1 Month Momentum % | 32.41 | |||||
| 12-1 Month Momentum % | 5.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.37 | |||||
| Days Inventory | 337.14 | |||||
| Days Sales Outstanding | 71.74 | |||||
| Days Payable | 14.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.49 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| 3-Year Dividend Growth Rate | 115.4 | |||||
| Forward Dividend Yield % | 3.49 | |||||
| 5-Year Yield-on-Cost % | 88.83 | |||||
| Shareholder Yield % | -11.64 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.51 | |||||
| Operating Margin % | 11.47 | |||||
| Net Margin % | 16.1 | |||||
| FCF Margin % | -21.13 | |||||
| ROE % | 13.57 | |||||
| ROA % | 5.92 | |||||
| ROIC % | 3.81 | |||||
| 3-Year ROIIC % | 3.17 | |||||
| ROC (Joel Greenblatt) % | 18.3 | |||||
| ROCE % | 10.78 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.43 | |||||
| Forward PE Ratio | 10.42 | |||||
| PE Ratio without NRI | 12.03 | |||||
| Shiller PE Ratio | 22.46 | |||||
| PEG Ratio | 0.49 | |||||
| PS Ratio | 2 | |||||
| PB Ratio | 1.36 | |||||
| Price-to-Tangible-Book | 1.41 | |||||
| Price-to-Operating-Cash-Flow | 29.15 | |||||
| EV-to-EBIT | 13.46 | |||||
| EV-to-EBITDA | 11.39 | |||||
| EV-to-Revenue | 2.75 | |||||
| EV-to-FCF | -13.16 | |||||
| Price-to-GF-Value | 0.55 | |||||
| Price-to-Projected-FCF | 1.65 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.7 | |||||
| Price-to-Graham-Number | 0.86 | |||||
| Earnings Yield (Greenblatt) % | 7.43 | |||||
| FCF Yield % | -10.84 | |||||
| Forward Rate of Return (Yacktman) % | 20 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Shin Nippon Biomedical Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 188.897 | ||
| EPS (TTM) (€) | 0.736 | ||
| Beta | -0.36 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 42.87 | ||
| 14-Day RSI | 38.58 | ||
| 14-Day ATR (€) | 0.176114 | ||
| 20-Day SMA (€) | 9.2075 | ||
| 12-1 Month Momentum % | 5.49 | ||
| 52-Week Range (€) | 6.25 - 11.5 | ||
| Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shin Nippon Biomedical Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shin Nippon Biomedical Laboratories Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shin Nippon Biomedical Laboratories Ltd Frequently Asked Questions
What is Shin Nippon Biomedical Laboratories Ltd(FRA:YB3)'s stock price today?
The current price of FRA:YB3 is €8.90. The 52 week high of FRA:YB3 is €11.50 and 52 week low is €6.25.
When is next earnings date of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3)?
The next earnings date of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is .
Does Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) pay dividends? If so, how much?
The Dividend Yield % of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is 3.49% (As of Today), Highest Dividend Payout Ratio of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) was 0.41. The lowest was 0.06. And the median was 0.14. The Forward Dividend Yield % of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is 3.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers